SCHEMBL7948827

SCHEMBL7948827

CCC(C)Oc1cc(N(Cc2cncnc2)c2cccc(C(=O)O)c2)ccc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 4/20 0.39
PDE4A P27815 3/20 0.39
PDE4C Q08493 3/20 0.39
PDE4D Q08499 3/20 0.39
MRGPRX4 Q96LA9 3/20 0.38
LTC4S Q16873 1/20 0.37
RXRA P19793 5/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
GRM2 Q14416 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.36
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3133069 0.92 RXRA (0.42) PDE4BPDE4APDE4CPDE4DMRGPRX4
SCHEMBL3131075 0.87 TSHR (0.46) PDE4BPDE4APDE4CPDE4DMRGPRX4
SCHEMBL3127770 0.85 TSHR (0.52) MRGPRX4LTC4SRXRAALDH1A1
SCHEMBL3126041 0.84 PDE4A (0.47) PDE4BPDE4APDE4CPDE4DLTC4S
SCHEMBL3125334 0.82 RXRA (0.52) PDE4BPDE4APDE4CPDE4DRXRA
SCHEMBL3129460 0.82 PDE4A (0.42) PDE4BPDE4APDE4CPDE4DMRGPRX4
SCHEMBL3117619 0.82 RXRA (0.41) PDE4BPDE4APDE4CPDE4DMRGPRX4
SCHEMBL3131336 0.82 PDE4A (0.53) PDE4BPDE4APDE4CPDE4DMRGPRX4
SCHEMBL4190635 0.82 GRM2 (0.44) PDE4BPDE4APDE4CPDE4DMRGPRX4
SCHEMBL3127725 0.81 MRGPRX4 (0.47) MRGPRX4LTC4SRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed
WO-2010003084-A2 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B PDE4B 2/4885PDE4A 1/4885PDE4C 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.